Business Wire1 个月
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial ...
Business Wire1 个月
Merck and Ridgeback Biotherapeutics Announce Initiation of Phase 3 Study (MOVe-NOW ...
RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate ...